不同剂量氯吡格雷对PCI术后血小板反应不全急性冠脉综合征患者疗效的影响

被引:9
|
作者
芦俊峰 [1 ]
程功 [2 ]
机构
[1] 西安北车医院
[2] 陕西省人民医院
关键词
氯吡格雷; 血小板反应不全; 急性冠脉综合征;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
摘要
目的观察比较不同剂量氯吡格雷对PCI术后血小板反应不全的急性冠脉综合征患者疗效的影响。方法血小板反应不全的急性冠脉综合征患者80例根据入院顺序分为治疗组与对照组各40例,2组均常规行PCI,对照组给予低负荷剂量氯吡格雷配合治疗,治疗组给予高负荷剂量的氯吡格雷配合治疗,观察2组疗效。结果 2组用药后血小板聚集率均明显下降(P均<0.05),在术后不同时间点,组内与组间对比均有显著性差异(P均<0.05)。治疗后治疗组有效率为98%,对照组为88%,2组比较有显著性差异(P<0.05)。术后随访30 d,2组均无死亡者,但治疗组的心肌梗死、靶血管血运重建和出血等总体并发症发生率明显低于对照组(P<0.05)。结论高剂量氯吡格雷可以更加有效地抑制血小板聚集,提高治疗有效率,明显改善预后,更适合于对血小板反应不全的ACS患者。
引用
收藏
页码:1399 / 1400
页数:2
相关论文
共 9 条
  • [1] 动脉粥样硬化血栓形成疾病的发病机制进展
    廖明芳
    景在平
    丁茹
    [J]. 国际病理科学与临床杂志, 2006, (02) : 106 - 109
  • [2] 氯吡格雷抵抗的机制与对策
    张永珍
    高炜
    [J]. 中华内科杂志, 2006, (03) : 250 - 252
  • [3] Advances in Antiplatelet Therapy: Agents in Clinical Development[J] . Dominick J. Angiolillo,Deepak L. Bhatt,Paul A. Gurbel,Lisa K. Jennings. The American Journal of Cardiology . 2009 (3)
  • [4] Preliminary experience with intravenous P2Y 12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial[J] . Adam B. Greenbaum,E. Magnus Ohman,C. Michael Gibson,Steven Borzak,Amanda L. Stebbins,Mei Lu,Michel R. Le May,Jill E. Stankowski,Hakan Emanuelsson,W. Douglas Weaver. American Heart Journal . 2007 (4)
  • [5] Impact of Clopidogrel on Suppression of Circulating Levels of Soluble CD40 Ligand in Patients With Unstable Angina Undergoing Coronary Stenting[J] . Hon-Kan Yip,Li-Teh Chang,Cheuk-Kwan Sun,Cheng-Hsu Yang,Wei-Chin Hung,Cheng-I. Cheng,Sarah Chua,Kuo-Ho Yeh,Chiung-Jen Wu,Morgan Fu. The American Journal of Cardiology . 2006 (2)
  • [6] Platelet Glycoprotein IIb/IIIa Polymorphism and Coronary Artery Disease[J] . Augusto Castelnuovo,Giovanni Gaetano,Maria Donati,Licia Iacoviello. American Journal of Pharmacogenomics . 2005 (2)
  • [7] Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization
    Mobley, JE
    Bresee, SJ
    Wortham, DC
    Craft, RM
    Snider, CC
    Carroll, RC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04): : 456 - 458
  • [8] Variability in platelet responsiveness to clopidogrel among 544 individuals[J] . Victor L. Serebruany,Steven R. Steinhubl,Peter B. Berger,Alex I. Malinin,Deepak L. Bhatt,Eric J. Topol. Journal of the American College of Cardiology . 2004 (2)
  • [9] Reduced inhibition by abciximab in platelets with the Pl A2 polymorphism[J] . Guy L. Wheeler,Gregory A. Braden,Paul F. Bray,Stanley J. Marciniak,Mary Ann Mascelli,David C. Sane. American Heart Journal . 2002 (1)